Nitrate Drugs - Isosorbide 5 Mononitrate Extended Release
|
Generic Name |
isosorbide 5 mononitrate extended release | |
| Strength | 60 mg | |
|
Form |
tablet | |
|
Criteria |
Approval Period |
|
1. Treatment failure on optimal dose of, or intolerance to, isosorbide dinitrate (ISDN). OR 2. Person identified as having unstable angina. |
Indefinite |
Practitioner Exemptions
Practitioners in the following specialty are not required to submit a Special Authority request form for coverage:
- Paediatric Cardiology
- Paediatrics
- Paediatric General Surgery
Special Notes
- None
